Hisamitsu Miyaaki

19PUBLICATIONS
55CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 09, 2026
Post-to Pretreatment Ratio of Serum CXCL10 Level Predicts Short-Term Liver Function Outcome in Compensated and Decompensated Cirrhotic Patients Due to Chronic Hepatitis C Virus Infection After Direct-Acting Antiviral Therapy.

Takanori Suzuki, Kentaro Matsuura, Yuki Tahata

|Feb 06, 2026
Response to 'Reassessing the Clinical Interpretation of Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma'.

Ryu Sasaki, Shigeo Shimose, Issei Saeki

|Dec 19, 2025
Plasma Vascular Endothelial Growth Factor-A Identified by Proximity Extension Assay Predicts Early Progression in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab.

Kazuaki Tajima, Satoshi Miuma, Ryu Sasaki

|Nov 28, 2025
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B.

Ryu Sasaki, Shigeo Shimose, Issei Saeki

|Nov 14, 2025
Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma.

Takanori Ito, Shigeo Shimose, Issei Saeki

|Oct 22, 2025
First Reported Case of Human Infection With Helicobacter cynogastricus.

Mayuko Kakizoe, Tomotaka Mori, Masaya Shigeno

Pageof 4

Frequent Collaborators

9 joint publications

Ryu Sasaki

6 joint publications

Taro Takami

6 joint publications

Shigeo Shimose

5 joint publications

Takumi Kawaguchi